Log In
BCIQ
Print this Print this
 

SetoFilm (ondansetron RapidFilm) (BA-030)

  Manage Alerts
Collapse Summary General Information
Company Applied Pharma Research S.A.
DescriptionDissolving oral film strip formulation of ondansetron using RapidFilm technology
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy- and radiation-induced nausea and vomiting; Treat post-operative nausea and vomiting (PONV)
Regulatory Designation
PartnerNorgine B.V.;
SciClone Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$64.6M

$8.9M

$48.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today